Argipressin0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Argipressin — research data
Regulatory statusFDA-approved (Pitressin)
NCAA D1Not listed
Overview
About Argipressin
Mechanism of action
Arginine vasopressin V1/V2 receptor agonist causing systemic vasoconstriction and antidiuresis
Safety profile
Cardiac ischemia, hyponatremia, peripheral ischemia, mesenteric ischemia · Long clinical history; vasoconstriction, hyponatremia possible; critical care staple
Related pages